Latest Advances in Stem Cell-Based Disease Modelling and Drug Screening

 

23-24 April, 2026 Copenhagen, Denmark

We are excited to announce that registration is now open for the upcoming stem cell symposium Latest Advances in Stem Cell-Based Disease Modelling and Drug Screening, co-organised by StemScreen and DASCS.

REGISTRATION

This vibrant event will bring together leading scientists in stem cell research, disease modelling, and drug discovery to share their latest breakthroughs and foster collaboration across academia, biotech, and pharma.

Highlights

  • Cutting-edge research on stem cell-derived disease models
  • Advances in organoid technology and 3D culture systems
  • Scalable platforms for drug screening and lead compound testing
  • Strategies for drug discovery and translation

Why Attend

  • Engage with world-renowned experts and emerging voices
  • Discover new tools and technologies shaping the future of drug discovery
  • Network with peers and potential collaborators
  • Become an abstract selected presenter to showcase your own research

Join us in Copenhagen to explore how stem cell technologies are redefining the landscape of biomedical research and therapeutic innovation.

Registration

Registration deadline: 20 February 2026

Visit StemScreen: https://stemscreen.ku.dk

We hope to see you there and thank you for the continuing support.

 

The DASCS Team

Confirmed speakers:

  • Christine Mummery – Professor of Developmental Biology, NNF Center for Stem Cell Medicine - reNEW and Leiden University Medical Center, The Netherlands
  • Lorenz Studer – Founding Director, SKI Center for Stem Cell Biology and Enid A. Haupt Chair in Developmental Biology, Memorial Sloan Kettering Cancer Center, USA
  • Ludovic Vallier – Einstein Professor for Stem Cells in Regenerative Therapies, Berlin Institute of Health @Charité and Max Planck Institute for Molecular Genetics, Germany
  • Peter Reinhardt – Principal Research Scientist II / Team Lead, Advanced Cell Technologies and Screening, Neuroscience Discovery Research, AbbVie, Germany
  • Lauriane Cabon – Group Lead - Applied Organoid Technologies, Roche Institute of Human Biology, Switzerland
  • Malene Ambjørn – Director, Functional & Cellular Pharmacology, Neuroscience, Lundbeck, Denmark
  • Henning Kempf – Head of Department, GEM CELL Hub, Novo Nordisk, Denmark
  • More speakers to be announced